Erasca ERAS
NASDAQ ERAS
$14.39 +0.35 (+2.49%)
At close: Oct 23, 2026 · 4:00 PM EDT

Erasca (ERAS) Price to Sales (2021 - 2026)

Updated

Analysis

Erasca (ERAS) Price to Sales (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Erasca 4.49 Bn 3.41 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 367.31
Mar 31, 2026 308.22
Dec 31, 2025 63.65
Sep 30, 2025 33.75
Jun 30, 2025 17.81
Mar 31, 2025 18.54
Dec 31, 2024 29.21
Sep 30, 2024 40.52
Jun 30, 2024 29.33
Mar 31, 2024 18.62
Dec 31, 2023 19.26
Sep 30, 2023 19.32
Jun 30, 2023 33.13
Mar 31, 2023 52.00
Dec 31, 2022 107.29
Sep 30, 2022 448.67
Jun 30, 2022 1,064.08
Mar 31, 2022 3,762.52
Dec 31, 2021 5,435.83
Sep 30, 2021 16,455.29
API Access

Erasca Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ERAS&period=max&api_key=YOUR_API_KEY